XML 45 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Operating activities      
Net loss $ (31,536) $ (27,019) $ (23,173)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization expense 1,352 482 444
Stock-based compensation expense 4,884 2,168 928
Non-cash interest expense 170 238 388
Gain on disposal of fixed assets (14)   11
Non-cash research and development expense for issuance of warrants to a vendor     2,078
Change in fair value of preferred stock warrants   90 307
Changes in operating assets and liabilities:      
Accounts receivable (983) (1,682) (1,655)
Deposits     200
Prepaid expenses and other assets (1,828) (273) 6
Inventory (1,603) (2,043) (526)
Other non-current assets 267    
Accounts payable 1,318 1,003 1,131
Accrued compensation and benefits, other accrued expenses and other liabilities 1,101 2,035 1,200
Deferred revenue (1,849) 2,895 919
Net cash used in operating activities (28,721) (22,106) (17,742)
Investing activities      
Purchases of property and equipment (1,518) (1,132) (526)
Acquisitions, net of cash acquired (3,801)   (300)
Purchase of investments (150)    
Proceeds from sale of assets 15    
Net cash used in investing activities (5,454) (1,132) (826)
Financing activities      
Proceeds from sale of preferred stock, net of issuance costs   65,575  
Proceeds from sale of common stock, net of issuance costs (20) 8,423 45,428
Proceeds from exercise of stock warrants   29 18
Proceeds from stock options exercised 1,871 202 213
Proceeds from the issuance of notes payable and warrants, net of issuance costs   (59) 2,954
Payments on notes payable (1,929) (921) (2,697)
Net cash (used in) provided by financing activities (78) 73,249 45,916
Net decrease in cash and cash equivalents (34,253) 50,011 27,348
Cash, restricted cash, and cash equivalents at beginning of period 79,682 29,671 2,323
Cash, restricted cash, and cash equivalents at end of period 45,429 79,682 29,671
Supplemental cash flow information      
Accretion of redeemable convertible preferred stock to redemption value   4,110 4,437
Cash paid for interest 660 743 945
Warrants issued to lenders   119 128
Purchases of property and equipment included in accounts payable 78 74 72
Fair value of common stock warrants exercised and reclassified as shares of common stock $ 196 $ 2,187 $ 5,257